[Reinforcement of warfarin action in a patient administered S-1]

Gan To Kagaku Ryoho. 2015 Jan;42(1):131-3.
[Article in Japanese]

Abstract

A case showing reinforcement of the action of warfarin and potassium in a patient administered S-1 is reported.The patient was a 71-year-old man with left upper gingival cancer.He had ventricular tachycardia (VT), hypertrophic cardiomyopathy, and a cerebellar infarction.He underwent a pacemaker implantation, and was administered warfarin.After the operation, in mid-March 2010, he was administered with S-1 and warfarin. However, the international normalized ratio of prothrombin time (PT-INR) increased to an extremely high level of 5.82, and S-1 and warfarin were stopped. They were re-administered at the end of April, and the PT-INR stabilized to approximately 2.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use*
  • Antimetabolites, Antineoplastic / therapeutic use
  • Cardiomyopathy, Hypertrophic / complications
  • Cardiomyopathy, Hypertrophic / drug therapy*
  • Cerebral Infarction / complications
  • Cerebral Infarction / drug therapy*
  • Drug Combinations
  • Drug Interactions
  • Humans
  • Male
  • Mouth Neoplasms / complications
  • Mouth Neoplasms / drug therapy*
  • Neoplasms, Squamous Cell / complications
  • Neoplasms, Squamous Cell / drug therapy*
  • Oxonic Acid / therapeutic use
  • Tachycardia, Ventricular / complications
  • Tachycardia, Ventricular / drug therapy*
  • Tegafur / therapeutic use
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Warfarin
  • Oxonic Acid